|
Re: Toxicity
|
5
|
Zenith Epigenetics
|
Mar 24, 2023 02:30PM
|
|
Re: well it shouldn't be long now....
|
2
|
Resverlogix Corp.
|
Mar 27, 2023 09:45PM
|
|
Re: Hump Day Fun
|
3
|
Resverlogix Corp.
|
Mar 29, 2023 02:50PM
|
|
Re: Hump Day Fun
|
5
|
Resverlogix Corp.
|
Mar 31, 2023 01:33PM
|
|
Re: Additional Exempt Distribution- 2023-03-31
|
3
|
Zenith Epigenetics
|
Apr 16, 2023 07:53PM
|
|
Sales could take a hit
|
3
|
Resverlogix Corp.
|
Apr 16, 2023 08:20PM
|
|
Re: Reverse Split Thoughts
|
3
|
Resverlogix Corp.
|
Apr 30, 2023 12:44PM
|
|
Re: Big Drop in Zenith today!
|
2
|
Zenith Epigenetics
|
May 06, 2023 12:46AM
|
|
Re: Big Drop in Zenith today!
|
1
|
Zenith Epigenetics
|
May 06, 2023 12:54PM
|
|
Re: IR - "but all I can tell you at the moment is that we believe we are making real progress towards achieving our goals."
|
3
|
Resverlogix Corp.
|
May 18, 2023 12:27PM
|
|
Re: RVX Long Covid Trial
|
2
|
Resverlogix Corp.
|
May 29, 2023 02:42AM
|
|
Re: Voting reminder
|
1
|
Resverlogix Corp.
|
Jun 08, 2023 08:24PM
|
|
Re: Voting reminder
|
2
|
Resverlogix Corp.
|
Jun 09, 2023 08:26PM
|
|
Re: Voting reminder
|
2
|
Resverlogix Corp.
|
Jun 11, 2023 10:40AM
|
|
Re: Voting reminder
|
|
Resverlogix Corp.
|
Jun 11, 2023 05:38PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 13, 2023 11:58AM
|
|
Breakthrough Therapy Designation
|
1
|
Resverlogix Corp.
|
Jun 13, 2023 12:19PM
|
|
Re: Breakthrough Therapy Designation
|
2
|
Resverlogix Corp.
|
Jun 13, 2023 12:26PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 14, 2023 09:18AM
|
|
Re: "Do we actually have a Breakthrough Therapy Designation?"
|
4
|
Resverlogix Corp.
|
Jun 14, 2023 03:37PM
|
